It's painful to look at.
Out of interest what happened to cause it to drop from $4 to around $1 in such a short period of time ? Presumably there was a fairly major news event that was the catalyst. Whatever they did to manage that seemed quite effective as there was a good recovery then it's been death by a thousand cuts from then on.
I still can't believe that a stage 3 Biotech with a theoretical 85% chance of success for a drug with a huge market is languishing at these levels.
Something is very wrong although maybe it will change once we are approved for stage 3 and the finances are sorted
Chart, page-4252
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $96.19M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1818 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 1000 | 1 |
View Market Depth
| Last trade - 08.48am 12/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |
Day chart unavailable